Stereotaxis, Inc.
STXS- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001289340
No open-market purchases or sales by Stereotaxis, Inc. insiders were filed in the last 90 days; 108 institutions reported holding it in 13F filings for Q2 2026, worth $74.1M in total; no superinvestor holds it.
Holders of 5% or more of STXS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Stereotaxis, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Lagoda Investment Management, L.P. | 13G | 5.10%4.38M shares | New | May 15, 20251 filing | May 15, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Stereotaxis, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 15, 20254:05 PM ET | Lagoda Investment Management, L.P. | 13G | 5.10%4.38M shares | New | Mar 31, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Stereotaxis, Inc. shares.
No Form 144 notices for Stereotaxis, Inc. are on file.